Equity Profile

SOLV

Solventum Corporation

Health CareHealth Care Supplies$14.7B

Aug6Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

Solventum Corporation operates in the health care supplies sector, providing essential products that support medical professionals and patients. With a market cap of $15 billion, the company plays a critical role in the health care supply chain, especially as demand for health-related products continues to grow.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be keen to see if Solventum continues its trend of beating expectations.

Expected to be around $1.50

Revenue Growth

While revenue estimates are not available, growth in this area is crucial for assessing the company's overall performance and market demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1 2026, Solventum reported an EPS of $1.48, surpassing estimates by 9.39%. The stock reacted positively, gaining 2.37% the following day.

Management Promises & Guidance

Continue to innovate in product development.
Focus on expanding market share in emerging markets.
Maintain cost control measures to improve profitability.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Solventum's upcoming earnings, given its strong track record of beating EPS estimates. However, the lack of revenue guidance raises some uncertainty.

Bull Case

If Solventum beats EPS expectations again, it could signal strong operational efficiency and market demand, potentially leading to a significant stock price increase.

Bear Case

Conversely, any signs of revenue stagnation or increased costs could lead to a negative reaction, especially if the company fails to meet its historical EPS performance.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $1.50

EPS is a key indicator of profitability, and investors will be keen to see if Solventum continues its trend of beating expectations.

Revenue Growth

N/A

While revenue estimates are not available, growth in this area is crucial for assessing the company's overall performance and market demand.

Gross Margin

N/A

A healthy gross margin indicates efficient cost management and pricing power, which are vital in the competitive health care supplies market.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and will it exceed the $1.50 mark?

Given Solventum's history of beating EPS estimates, this number will be critical for investor confidence.

How is the company managing costs and what is the outlook for gross margins?

Understanding cost management and margin outlook will provide insight into the company's profitability and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to manage costs effectively, which could lead to better-than-expected margins despite rising input costs.

Supporting Evidence

The company's consistent EPS beat rate suggests strong operational management.

Options pricing indicates a significant potential move, reflecting uncertainty that could be resolved positively.

Historical performance shows that Solventum has a strong track record of navigating market challenges.

Key Risk

If gross margins improve significantly, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Solventum can maintain its strong EPS track record amidst rising costs and market pressures.

Bull Confirmed If

An EPS of $1.55 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $1.45 would support the bear case, suggesting potential issues in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by around 1.14% the next day, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 2.08%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Details on product innovation and market expansion efforts.
3Insights into demand trends for health care supplies.
4Management's outlook on competitive pressures in the industry.
5Any commentary on supply chain challenges and resolutions.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Danaos Corporation

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability, and investors will be keen to see if Solventum continues its trend of beating expectations.

Expected to be around $1.50

Revenue Growth

While revenue estimates are not available, growth in this area is crucial for assessing the company's overall performance and market demand.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SOLV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+10.27%

Avg Stock Reaction

+1.14%

Last Quarter Recap

In Q1 2026, Solventum reported an EPS of $1.48, surpassing estimates by 9.39%. The stock reacted positively, gaining 2.37% the following day.

Management Promises & Guidance

Continue to innovate in product development.
Focus on expanding market share in emerging markets.
Maintain cost control measures to improve profitability.

Expectations

Wall Street Expectations

Investors are cautiously optimistic about Solventum's upcoming earnings, given its strong track record of beating EPS estimates. However, the lack of revenue guidance raises some uncertainty.

Bull Case

If Solventum beats EPS expectations again, it could signal strong operational efficiency and market demand, potentially leading to a significant stock price increase.

Bear Case

Conversely, any signs of revenue stagnation or increased costs could lead to a negative reaction, especially if the company fails to meet its historical EPS performance.

Key Metrics to Watch

Earnings Per Share (EPS)

Expected to be around $1.50

EPS is a key indicator of profitability, and investors will be keen to see if Solventum continues its trend of beating expectations.

Revenue Growth

N/A

While revenue estimates are not available, growth in this area is crucial for assessing the company's overall performance and market demand.

Gross Margin

N/A

A healthy gross margin indicates efficient cost management and pricing power, which are vital in the competitive health care supplies market.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be for Q2-2026, and will it exceed the $1.50 mark?

Given Solventum's history of beating EPS estimates, this number will be critical for investor confidence.

How is the company managing costs and what is the outlook for gross margins?

Understanding cost management and margin outlook will provide insight into the company's profitability and operational efficiency.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Solventum's ability to manage costs effectively, which could lead to better-than-expected margins despite rising input costs.

Supporting Evidence

The company's consistent EPS beat rate suggests strong operational management.

Options pricing indicates a significant potential move, reflecting uncertainty that could be resolved positively.

Historical performance shows that Solventum has a strong track record of navigating market challenges.

Key Risk

If gross margins improve significantly, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on whether Solventum can maintain its strong EPS track record amidst rising costs and market pressures.

Bull Confirmed If

An EPS of $1.55 or higher would confirm the bull case and indicate strong operational performance.

Bear Confirmed If

An EPS below $1.45 would support the bear case, suggesting potential issues in profitability.

Pre-Earnings Positioning

Options Market

Implied Move

±14.54%

Historical Avg

±2.1%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±14.5% while SOLV has averaged ±2.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

24.1%

Calls (8K)P/C Ratio: 2.14Puts (400)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Solventum beats expectations, history suggests the stock could rise by around 1.14% the next day, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with historical patterns indicating a potential drop of around 2.08%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on cost management strategies and their impact on margins.
2Details on product innovation and market expansion efforts.
3Insights into demand trends for health care supplies.
4Management's outlook on competitive pressures in the industry.
5Any commentary on supply chain challenges and resolutions.